Care
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.
The industrial giant plans to retain a stake of almost 20% in GE Healthcare.
Cue received emergency use authorization for its at-home COVID-19 test in March and went public in September.
SPONSORED
|
03:00 pm |
November 09, 2021
|
03:00 pm |
November 09, 2021
Philips is developing connected care for the future. Business Leader for Clinical Data Services, Elad Benjamin, discusses a time of digital transformation.
The company said the latest round brings its total raise to $47 million.
The tool uses information about pain level, condition and current medication regimen to find an effective dose of opioids.
The scheme is being run in partnership with government technology firm PUBLIC.
The pair aim to make AI-enhanced diagnostics accessible beyond hospital settings.
The senior advisor for population health at the Council of Cooperative Health Insurance in Saudi Arabia gives insights for improving patient outcomes.
The plan, built with Trustmark Health Benefits, is centered on Teladoc’s primary care offering, recently made available to payers.